Seroatlas · Human Serome Atlas

GYPA

Glycophorin-A

Also known as: CD235a, GLPA_HUMAN, GPA, MN, MNS

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P02724
Gene
GYPA
Ensembl
ENSG00000170180
Chromosome
4
Canonical length
150 aa
Protein class
Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters
Subcellular location
Nucleoplasm,Plasma membrane,Cytosol
Quaternary structure
Homodimer

OverviewNCBI Gene

Glycophorins A (GYPA) and B (GYPB) are major sialoglycoproteins of the human erythrocyte membrane which bear the antigenic determinants for the MN and Ss blood groups. In addition to the M or N and S or s antigens that commonly occur in all populations, about 40 related variant phenotypes have been identified. These variants include all the variants of the Miltenberger complex and several isoforms of Sta, as well as Dantu, Sat, He, Mg, and deletion variants Ena, S-s-U- and Mk. Most of the variants are the result of gene recombinations between GYPA and GYPB. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

150 residues, UniProt reviewed canonical sequence.

>P02724|GYPA
     1  MYGKIIFVLL LSEIVSISAL STTEVAMHTS TSSSVTKSYI SSQTNDTHKR DTYAATPRAH
    61  EVSEISVRTV YPPEEETGER VQLAHHFSEP EITLIIFGVM AGVIGTILLI SYGIRRLIKK
   121  SPSDVKPLPS PDTDVPLSSV EIENPETSDQ

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GYPA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.63
Highest tissue expression
147 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 147 nTPM
  • placenta: 3.8 nTPM
  • spleen: 2.3 nTPM
  • kidney: 2.2 nTPM
  • liver: 0.5 nTPM
  • lung: 0.4 nTPM

Single-cell type

  • erythrocyte progenitors: 235 nCPM
  • erythrocytes: 111 nCPM
  • proximal tubule cells: 4.8 nCPM
  • epicardial cells: 2.3 nCPM
  • brain inhibitory neurons: 2 nCPM
  • brain excitatory neurons: 1.7 nCPM

Immune cell

  • naive B-cell: 0.1 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM

Brain region

  • cerebral cortex: 12 nTPM
  • white matter: 7.7 nTPM
  • basal ganglia: 7.3 nTPM
  • amygdala: 5.7 nTPM
  • pons: 5.2 nTPM
  • thalamus: 4.8 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GYPA.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 21 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.16
gnomAD pLI
0
gnomAD missense Z
-0.55
DepMap mean gene effect
0.08
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of GYPA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GYPA as an antibody target. Whether an autoantibody or antibody against GYPA could matter depends on whether native GYPA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GYPA is annotated at the cell surface, where native GYPA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label GYPA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GYPA. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...